KCAS Acquires France-based Active Biomarkers

KCAS Bioanalytical Acquires FlowMetric, LLC

February 3, 2022

Biotechnology

KCAS Bioanalytical and Biomarker Services, a Vitruvian Partners-backed CRO, has acquired FlowMetric, LLC, a provider of flow cytometry and cellular assay R&D services. The add-on expands KCAS's cell and gene therapy capabilities and accelerates its international footprint with FlowMetric's locations in Doylestown, Pennsylvania and Milan, Italy.

Bruker Corporation Acquires biocrates life sciences ag

June 3, 2025

Biotechnology

Bruker Corporation has acquired biocrates life sciences ag, an Innsbruck, Austria-based leader in mass-spectrometry-based quantitative metabolomics. The deal adds biocrates' metabolomics kits, assays, software and contract research services to Bruker's multiomics strategy, expanding Bruker's MS-based metabolomics and integrated multiomics capabilities. Financial terms were not disclosed.

GBA Group Acquires KaLy-Cell SAS

September 5, 2022

Biotechnology

GBA Group has acquired French contract research organization KaLy-Cell SAS, marking the group's market entry into France and expanding its European pharmaceutical network. KaLy-Cell, founded in 2003 as a spin-off from the University of Bourgogne Franche-Comté and headquartered in Plobsheim, provides hepatocyte-based in vitro contract research and safety testing services for pharmaceuticals, agrochemicals and cosmetics.

Accel-KKR Acquires MOA Benchmarking

September 28, 2025

Healthcare Services

Accel-KKR, a technology-focused private equity firm, has acquired MOA Benchmarking, a quality-improvement platform serving aged care, retirement living, and disability service providers across Australia. The acquisition is intended to deepen collaboration with Accel-KKR portfolio company Health Metrics to integrate analytics and clinical/operational management capabilities and accelerate product innovation for care providers.

Bruker Corporation Acquires Canopy Biosciences, LLC

September 11, 2020

Biotechnology

Bruker Corporation has acquired Canopy Biosciences, LLC to strengthen its targeted multi-omics and high-plex biomarker imaging capabilities, adding Canopy's ChipCytometry platform and multi-omics services. Financial terms were not disclosed; Ampersand Capital Partners was identified as Canopy's lead investor.

Taconic Biosciences Acquires TransCure bioServices

January 20, 2026

Biotechnology

Taconic Biosciences has acquired TransCure bioServices SAS to create an integrated global translational research platform combining Taconic's genetically engineered and humanized mouse models with TransCure's preclinical in vivo services. The deal expands Taconic's capabilities across oncology, immunology, infectious disease, and advanced modalities while preserving TransCure's brand and operational structure to ensure continuity for employees and clients.